PT3197556T - Composição para a prevenção e/ou tratamento de sintomas de alergia - Google Patents

Composição para a prevenção e/ou tratamento de sintomas de alergia

Info

Publication number
PT3197556T
PT3197556T PT157917378T PT15791737T PT3197556T PT 3197556 T PT3197556 T PT 3197556T PT 157917378 T PT157917378 T PT 157917378T PT 15791737 T PT15791737 T PT 15791737T PT 3197556 T PT3197556 T PT 3197556T
Authority
PT
Portugal
Prior art keywords
prevention
treatment
composition
allergy symptoms
allergy
Prior art date
Application number
PT157917378T
Other languages
English (en)
Original Assignee
Ntc S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ntc S R L filed Critical Ntc S R L
Publication of PT3197556T publication Critical patent/PT3197556T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT157917378T 2014-09-22 2015-09-21 Composição para a prevenção e/ou tratamento de sintomas de alergia PT3197556T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20141641 2014-09-22

Publications (1)

Publication Number Publication Date
PT3197556T true PT3197556T (pt) 2024-01-16

Family

ID=51799187

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157917378T PT3197556T (pt) 2014-09-22 2015-09-21 Composição para a prevenção e/ou tratamento de sintomas de alergia

Country Status (13)

Country Link
US (2) US10143715B2 (pt)
EP (1) EP3197556B1 (pt)
CA (1) CA2958174C (pt)
DK (1) DK3197556T3 (pt)
ES (1) ES2968372T3 (pt)
FI (1) FI3197556T3 (pt)
HR (1) HRP20240090T1 (pt)
MX (1) MX2017003360A (pt)
PL (1) PL3197556T3 (pt)
PT (1) PT3197556T (pt)
RS (1) RS65173B1 (pt)
SI (1) SI3197556T1 (pt)
WO (1) WO2016046728A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107660794A (zh) * 2017-08-31 2018-02-06 王双亮 一种药食同源槐米的制备方法
IT202100021659A1 (it) * 2021-08-10 2023-02-10 A&R Pharma Srl Composizione topica e suo uso per il trattamento nasale della rinite
IT202200002108A1 (it) * 2022-02-07 2023-08-07 Indena Spa Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari
US20230338274A1 (en) * 2022-04-22 2023-10-26 Dermacisen, S.A. Food supplement for hair care and hair loss prevention.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001114686A (ja) * 1999-10-15 2001-04-24 Sunstar Inc Th2サイトカイン発現抑制剤
IT1315252B1 (it) 1999-10-21 2003-02-03 Truffini & Regge Farmaceutici Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
IT1393841B1 (it) * 2009-04-30 2012-05-11 Giuliani Spa Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
BR112012010586A2 (pt) * 2009-11-06 2016-03-22 Alcon Res Ltd suplementos nutricionais para alívio de segura no olho.

Also Published As

Publication number Publication date
DK3197556T3 (da) 2024-01-22
CA2958174C (en) 2023-08-15
WO2016046728A1 (en) 2016-03-31
ES2968372T3 (es) 2024-05-09
US10143715B2 (en) 2018-12-04
US10238707B2 (en) 2019-03-26
HRP20240090T1 (hr) 2024-04-26
SI3197556T1 (sl) 2024-03-29
RS65173B1 (sr) 2024-03-29
PL3197556T3 (pl) 2024-04-15
US20170258864A1 (en) 2017-09-14
CA2958174A1 (en) 2016-03-31
EP3197556B1 (en) 2023-11-01
FI3197556T3 (fi) 2024-01-19
US20180296621A1 (en) 2018-10-18
EP3197556A1 (en) 2017-08-02
MX2017003360A (es) 2017-06-21

Similar Documents

Publication Publication Date Title
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
HK1249851A1 (zh) 使用聚維酮碘的普通感冒的治療和預防
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
SG11201702554QA (en) Compositions and methods for the treatment of multiple sclerosis
PL3522921T3 (pl) Zapobieganie alergii
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
FI3197556T3 (fi) Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi
HK1225994A1 (zh) 用於治療過敏性病症的組合物
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
EP3131635A4 (en) Compositions and methods for the treatment or prevention of neurodegenerative disorders
HK1246271A1 (zh) 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途
HK1243961A1 (zh) 炎性病况的預防和治療
IL252493A0 (en) Compounds for use in the prevention or treatment of cancer
PT3191112T (pt) Compostos de dipeptidilcetoamida e sua utilização para o tratamento e/ou prevenção da acumulação de gordura
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
IL247616B (en) Centrally acting acetylcholinesterase inhibitors for the prevention/or treatment of chemically induced neurodegenerative diseases and their symptoms, and corresponding compositions, uses, methods and kit
EP3104940A4 (en) Compositions and methods for the prevention and/or treatment of schistosomiasis
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
GB201522828D0 (en) Prevention and treatment of glaucoma
SG11201704282UA (en) Compositions and methods for the treatment of multiple sclerosis
EP3223828A4 (en) Methods for the treatment and prevention of asbestos-related diseases
GB201518489D0 (en) Methods for the treatment and prevention of ebola